Related Experiment Video

Updated: Aug 11, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

Influence of chronic liver disease on coronary atherosclerosis vulnerability features

Roberto Otsubo1, Maria de Lourdes Higuchi, Paulo Sampaio Gutierrez

  • 1Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, Brazil.

International Journal of Cardiology
|March 1, 2006
PubMed

Insights

Patients with chronic liver disease exhibit less vulnerable coronary artery plaques, featuring smaller intimal areas and reduced inflammation. This suggests a lower susceptibility to complicated coronary atherosclerosis in individuals with liver conditions.

Area of Science:

  • Cardiovascular Pathology
  • Hepatology
  • Atherosclerosis Research

Background:

  • Previous studies indicate a reduced incidence of acute myocardial infarction among patients with chronic liver disease.
  • This observation suggests a potential protective effect of liver disease on coronary artery health.

Purpose of the Study:

  • To investigate the influence of chronic liver disease on the characteristics of atherosclerotic plaques in human coronary arteries.
  • Specifically analyzing plaque vulnerability markers.

Main Methods:

  • Histological examination of coronary artery segments from 114 individuals across three groups: chronic liver disease patients, natural cause deaths, and accidental deaths.
  • Evaluation of plaque area, luminal area, inflammation, fat percentage, and total vessel area.

Main Results:

  • Chronic liver disease patients (Group A) demonstrated significantly smaller plaque areas and lower rates of severe plaque inflammation compared to control groups (p<0.01).
  • No significant differences were observed in total vessel area, luminal obstruction, or plaque fat content between the groups.

Conclusions:

  • Chronic liver disease is associated with coronary arteries exhibiting smaller intimal plaques and decreased inflammation.
  • These findings support the hypothesis that patients with hepatic disease are less prone to developing complicated coronary atherosclerosis.
Abstract

More Related Videos

Hepatic Glucose Production, Ureagenesis, and Lipolysis Quantified using the Perfused Mouse Liver Model06:21

Hepatic Glucose Production, Ureagenesis, and Lipolysis Quantified using the Perfused Mouse Liver Model

Published on: October 6, 2023

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...